Jared Gollob, the Chief Medical Officer of $KYMR, sold 3,114 shares of the company on 10-13-2025 for an estimated $186,840. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.6% of their shares of this class of stock. Following this trade, they now own 118,359 shares of this class of $KYMR stock.
$KYMR Insider Trading Activity
$KYMR insiders have traded $KYMR stock on the open market 16 times in the past 6 months. Of those trades, 5 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $KYMR stock by insiders over the last 6 months:
- BROS. ADVISORS LP BAKER has made 2 purchases buying 655,500 shares for an estimated $28,842,000 and 0 sales.
- PARTNERS L P/IL BVF has made 3 purchases buying 317,167 shares for an estimated $13,955,348 and 0 sales.
- BRUCE N. JACOBS (Chief Financial Officer) sold 79,220 shares for an estimated $3,961,380
- NELLO MAINOLFI (Chief Executive Officer) has made 0 purchases and 2 sales selling 60,000 shares for an estimated $2,940,000.
- ELENA RIDLOFF has made 0 purchases and 3 sales selling 16,500 shares for an estimated $778,200.
- JEFFREY W. ALBERS has made 0 purchases and 2 sales selling 11,349 shares for an estimated $607,050.
- PAMELA ESPOSITO sold 5,000 shares for an estimated $245,185
- JARED GOLLOB (Chief Medical Officer) sold 3,114 shares for an estimated $186,840
- JEREMY G CHADWICK (Chief Operating Officer) sold 2,575 shares for an estimated $75,435
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KYMR Hedge Fund Activity
We have seen 131 institutional investors add shares of $KYMR stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,022,760 shares (+23.2%) to their portfolio in Q2 2025, for an estimated $44,633,246
- CAPITAL RESEARCH GLOBAL INVESTORS added 896,992 shares (+245.6%) to their portfolio in Q2 2025, for an estimated $39,144,730
- JANUS HENDERSON GROUP PLC removed 751,274 shares (-97.5%) from their portfolio in Q2 2025, for an estimated $32,785,597
- BAKER BROS. ADVISORS LP added 655,500 shares (+10.9%) to their portfolio in Q2 2025, for an estimated $28,606,020
- DEERFIELD MANAGEMENT COMPANY, L.P. added 653,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $28,496,920
- WELLINGTON MANAGEMENT GROUP LLP removed 624,812 shares (-10.4%) from their portfolio in Q2 2025, for an estimated $27,266,795
- CITADEL ADVISORS LLC added 516,382 shares (+20614.1%) to their portfolio in Q2 2025, for an estimated $22,534,910
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KYMR Analyst Ratings
Wall Street analysts have issued reports on $KYMR in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 10/01/2025
- Truist Securities issued a "Buy" rating on 09/30/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/18/2025
- RBC Capital issued a "Outperform" rating on 09/16/2025
- Wells Fargo issued a "Overweight" rating on 06/26/2025
- B. Riley Securities issued a "Buy" rating on 06/03/2025
- Morgan Stanley issued a "Overweight" rating on 06/03/2025
To track analyst ratings and price targets for $KYMR, check out Quiver Quantitative's $KYMR forecast page.
$KYMR Price Targets
Multiple analysts have issued price targets for $KYMR recently. We have seen 14 analysts offer price targets for $KYMR in the last 6 months, with a median target of $61.5.
Here are some recent targets:
- Jeff Jones from Oppenheimer set a target price of $63.0 on 10/01/2025
- Srikripa Devarakonda from Truist Securities set a target price of $68.0 on 09/30/2025
- Andrew S. Fein from HC Wainwright & Co. set a target price of $70.0 on 09/18/2025
- Etzer Darout from Barclays set a target price of $60.0 on 09/17/2025
- Brian Abrahams from RBC Capital set a target price of $70.0 on 09/16/2025
- Derek Archila from Wells Fargo set a target price of $53.0 on 06/26/2025
- Kalpit Patel from B. Riley Securities set a target price of $60.0 on 06/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
